# Duetact

NDC: 64764-304
Generic name: pioglitazone and glimepiride
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20060728

FDA application: NDA021925

## Active ingredients

- GLIMEPIRIDE: 4 mg/1
- PIOGLITAZONE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-304"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-304
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8b0c917-3fdd-4a28-a47d-6225b8195458